A reported 57% plunge followed a court finding against Yutrepia. That market reaction is now the foc

[url="]Schall, Brown and Schwartz[/url] LLP (“SBS”), a national shareholder rights litigation fi

LOS ANGELES--(BUSINESS WIRE)---- $LQDA--LQDA Investors with $100,000 in Losses Have Opportunity to J

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered L

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating pot

A court finding that Yutrepia infringed two valid claims of United Therapeutics' '327 patent has put

LQDA shareholders who lost money after a court found that Yutrepia infringed two valid United Therap

Liquidia Corporation (NASDAQ: LQDA - Get Free Report) shares dropped 6.1% on Monday after Wells Farg

Wells Fargo analyst Benjamin Burnett downgrades Liquidia (NASDAQ:LQDA) from Overweight to Equal-W

HC Wainwright & Co. analyst Andrew S. Fein maintains Liquidia (NASDAQ:LQDA) with a Buy and lo

LQDA faces a major setback as a patent ruling threatens Yutrepia's PH-ILD indication and creates unc

Analysts raised targets for HPE, Phillips 66, Micron and AEON; cut targets for Liquidia, Apple and Z

United Therapeutics secures a key patent ruling against Liquidia, potentially limiting Yutrepia's PH

Raymond James analyst Ryan Deschner downgrades Liquidia (NASDAQ:LQDA) from Strong Buy to Outperfo

Shares of Liquidia Corp (NASDAQ: LQDA) are sliding Thursday morning, extending a sell-off triggered

Analysts downgraded Liquidia, Sigma Lithium, ExxonMobil, Ormat Technologies and Ethos Technologies,

A single court ruling sent one pulmonary hypertension drugmaker soaring and left its rival fighting

Shares of United Therapeutics Corp. (NASDAQ:UTHR) are rising in Thursday morning trading following a

Gainers DataMEDS AI (NASDAQ:MEDS) stock moved upwards by 39.4% to $4.42 during Thursday's pre-m

U.S. stock futures were mixed as Progress Software fell after results; Corteva, NFT, Vivakor and oth

Needham analyst Serge Belanger maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price t

Liquidia Corp. shares gained 0.13% after hours after closing 57.19% lower following an adverse paten

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation

Liquidia shares plunged nearly 50% on Wednesday after a federal judge ruled that its lung drug infri

YUTREPIA's adoption is translating into profits and cash, giving Liquidia an operating foundation fo

LQDA's Yutrepia drives rapid growth, while ALKS benefits from a diversified portfolio, Lumryz and a

District Court ruled that two of the six claims asserted against Liquidia are valid and infringed Pa

Gainers NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 147.1% to $0.18 during Wednesday'

Liquidia Corporation (NASDAQ: LQDA - Get Free Report) shares traded up 4.2% on Monday. The stock tra

On September 28, 2026, Liquidia Corp (LQDA) shares rose by 7.7%, reaching a current price of $73.67.

U.S. stocks fell Monday, while Kodiak Sciences surged 174% after positive Phase 3 eye disease trial

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Liquidia's Yutrepia posts rapid sales growth, but intensifying competition from established therapie

Liquidia stock rises after the FDA grants Fast Track status to YUTREPIA for treating Raynaud’s pheno

Liquidia Corporation (NASDAQ:LQDA), a biopharmaceutical company driven by science and compassion to

Wells Fargo analyst Benjamin Burnett maintains Liquidia (NASDAQ:LQDA) with a Overweight and raise

Top analysts changed outlook on top names. Truist, Morgan Stanley, B of A Securities, HC Wainwright,

B of A Securities analyst Jason Gerberry maintains Liquidia (NASDAQ:LQDA) with a Neutral and rais

LifeSci Capital analyst Gaurav Maini downgrades Liquidia (NASDAQ:LQDA) from Outperform to Market

Needham analyst Serge Belanger maintains Liquidia (NASDAQ:LQDA) with a Buy and raises the price t

BTIG analyst Julian Harrison maintains Liquidia (NASDAQ:LQDA) with a Buy and raises the price tar

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Liquidia (NASDAQ:LQDA) reported quarterly earnings of $0.74 per share which beat the analyst consens

Top Wall Street analysts upgraded and downgraded several top companies, including Applied Materials,

Top Wall Street analysts changed outlook on top stocks. See all changes including upgrades, downgrad

Wall Street analysts changed outlook on top names. For full view of analyst rating changes, see anal

US stocks rise, Nasdaq up 0.3%. Liquidia Corp (LQDA) beats Q1 expectations, shares rise 15.7%. Other